Boston Scientific, ECRI Settle Price Transparency Case
This article was originally published in The Gray Sheet
Executive Summary
Boston Scientific and the ECRI Institute have settled a case about price transparency in the medical device industry, just as the issue is gaining prominence on Capitol Hill
You may also be interested in...
GAO Report Renews Debate Over Device Price Confidentiality
Hospitals, group purchasing organizations and other health care stakeholders want Congress to do away with pricing confidentiality clauses in purchase contracts for implantable devices, but industry wants to maintain its ability to keep device prices secret.
GAO Report Renews Debate Over Device Price Confidentiality
Hospitals, group purchasing organizations and other health care stakeholders want Congress to do away with pricing confidentiality clauses in purchase contracts for implantable devices, but industry wants to maintain its ability to keep device prices secret.
Device Firms Would Have To Report Sales Prices To CMS Under Senate Bill
A bill introduced Oct. 23 in the Senate would require device makers seeking Medicare reimbursement to report to CMS the prices they negotiate with hospitals and other buyers for all implantable medical devices